Long-term visual outcome of childhood blepharokeratoconjunctivitis.
OBJECTIVE
To assess the visual outcome of childhood blepharokeratoconjunctivitis.


METHODS
Retrospective noncomparative case series.


METHODS
We reviewed visual acuity and corneal examination results for 23 patients (mean age 19 +/- 4 years, range, 11 to 26 years) who had healed more than three years previously (up to 15 years).


RESULTS
The disease involved 29 eyes and was unilateral in 17 children. Corneal sequelae (neovascularization or scars) involved 18 eyes (62%) of 15 children (65%). Mean best-corrected visual acuity was 20/25 (range, 20/100 to 20/20). Best-corrected visual acuity was no more than 20/30 in seven eyes (24%) of seven children (30%). Fifteen eyes (52%) of 13 children (45%) had astigmatisms of at least 0.75 diopters attributable to corneal scars.


CONCLUSIONS
Corneal and visual sequelae are frequent in childhood blepharokeratoconjunctivitis. Early diagnosis and specific treatment are mandatory.
Doan
Serge
S
Department of Ophthalmology, Bichat Hospital and Fondation A. de Rothschild, Paris, France. serge.doan@noos.fr
Gabison
Eric E
EE
Nghiem-Buffet
Sylvia
S
Abitbol
Olivia
O
Gatinel
Damien
D
Hoang-Xuan
Thanh
T
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001762:Blepharitis / Q000188:drug therapy / Q000503:physiopathology*; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005672:Fusidic Acid / Q000627:therapeutic use; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy / Q000503:physiopathology*; D018942:Macrolides / Q000627:therapeutic use; D008297:Male; D012189:Retrospective Studies; D013752:Tetracycline / Q000627:therapeutic use; D014792:Visual Acuity / Q000502:physiology*
D000900:Anti-Bacterial Agents; D018942:Macrolides; D005672:Fusidic Acid; D013752:Tetracycline